Updated 2/16/2021 Updates were reviewed by Shazia K. Nakhoda, MD While lymphoma is the most common type of blood cancer, there are many different subtypes that require nuanced treatment. Because of this, getting an accurate diagnosis and receiving ind...
Read MoreCAR T-Cell Therapy 101—Your Questions Answered
Q. What is Chimeric Antigen Receptor (CAR) T-cell Therapy? A. CAR T-cell therapy is just one kind of immunotherapy. In CAR T-cell therapy, immune cells known as T cells are extracted from a patient’s blood. They are then genetically altered to recognize ...
Read MoreCAR T-Cell Therapy 101—Your Questions Answered
Elizabeth Plimack: Leading the Way in Bladder Cancer Clinical Trials
Immunotherapy has been the most exciting development in bladder cancer treatment in recent years. Its introduction ended a 40-year drought during which no new therapies were available. Unfortunately, many bladder cancers can be resistant to immunotherapy. ...
Read MoreElizabeth Plimack: Leading the Way in Bladder Cancer Clinical Trials
Immunotherapy 101: Your Questions Answered
Few breakthroughs in battling cancer have generated more excitement recently than immunotherapy. It’s helping some patients—including high profile ones like former president Jimmy Carter—achieve long-term remission and possibly even a cure when their cancer...
Read MoreImmunotherapy 101: Your Questions Answered
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this